About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,707 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,707 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2021-2040 of 3,707 trials

CompletedImpact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)The investigation will involve a double-blind, placebo controlled, cross-over study examining the efficacy of armodafinil in improving neurocognitive functioning and reducing…NCT00981084·Kansas City, Kansas UnknownEvaluation of Clinical, Morphologic and Biochemical Markers in Multiple SclerosisBy combining clinical, morphological and biochemical markers a better understanding of the formation and progression of multiple sclerosis (MS) should be obtainedNCT04892134·Graz, Styria CompletedTENS in Persons With MSPersons with multiple sclerosis (pwMS) often have an increased sense of fatigue.NCT05321927·Groningen, Provincie Groningen

Related Searches

Data from ClinicalTrials.govTerms

UnknownFamciclovir in Multiple SclerosisThis is a proof-of-concept study in 30 patients with established Relapsing Remitting Multiple Sclerosis (RRMS). IMP is Famciclovir.NCT05283551·London

WithdrawnImproving Memory in Patients With Multiple SclerosisPeople with multiple sclerosis (MS) suffer from cognitive and other brain problems.NCT00062972·Stony Brook, New York

TerminatedPredicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)Sphingosine 1-Phosphate (S1P) receptor modulators (S1PRMs) are part of the evolving treatment landscape of Multiple Sclerosis (MS) immunotherapies.NCT05828901·Bern

CompletedEvaluation of a Spasticity Management Program for People With Multiple SclerosisThis study will examine the impacts of two different methods of managing MS-related spasticity of the lower limbs.NCT03166930·Portland, Oregon

UnknownThe Effect of Transcranial Direct Current Stimulation on Fatigue Among Multiple Sclerosis Patients.PatientsThis work is aimed to assess the long term effect of TDCS in fatigue management among MS patientsNCT05560139

WithdrawnRESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple SclerosisRESET-MS: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Participants with Multiple…NCT07006805

CompletedAerobic Exercise for Remyelination in Multiple SclerosisThis is a clinical trial to determine the feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people…NCT04539002·Portland, Oregon

Not yet recruitingA Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple SclerosisThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of oral arbaclofen ER tablets in MS patients with…NCT05179577

TerminatedRivastigmine in Multiple Sclerosis Patients With Cognitive ImpairmentThis study evaluated the efficacy and safety of 10 cm² rivastigmine patch vs. placebo in cognitively impaired Multiple Sclerosis (MS) patients.NCT00881205·Aachen and 48 others

CompletedA 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple SclerosisThe purpose of this study is to evaluate the change in patient-reported outcomes, physician assessment of a change as well as safety and tolerability in patients with Relapsing…NCT01216072·Birmingham, Alabama and 148 others

CompletedA 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS PatientsThe primary purpose of this study is to demonstrate pharmacokinetic bioequivalence of ofatumumab injected by Pre-filled Syringe (PFS) versus Auto-Injector (AI) devices and thereby…NCT03560739·Fullerton, California and 40 others

CompletedStudy to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )This study determines the Annualized Relapse Rate (ARR) in participants with RMS after 96 weeks (approximately 2 years) treatment with intravenous (IV) infusion of…NCT03277261·Carlsbad, California and 13 others

UnknownAn Online Lifestyle Modification Course for People With Multiple SclerosisLifestyle factors are known to affect the progression of multiple sclerosis (MS).NCT05374473·Melbourne, Victoria

CompletedAnesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis MedicationsThe purpose of this study is to see if applying an anesthetic topical adhesive, Synera®, will reduce the injection pain.NCT01834586·Kirkland, Washington

CompletedEffects of Cycling and Virtual Reality on Thinking Speed in Persons With MS (PACE-MS)To compare the effects of cycling exercise with different types of virtual reality on processing/thinking speed in persons with multiple sclerosis (MS).NCT06191380·East Hanover, New Jersey

UnknownVirtual Reality and Robot Assisted Gait Training in Patients With Multiple SclerosisMultiple Sclerosis (MS), the most common non-traumatic cause of neurologic disability in young adults, affects mobility and ambulation in the majority of patients.NCT02896179·Verona, Verona

RecruitingStudy of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)The Service Hospitalier Frédéric-Joliot (SHFJ) and Paris Brain Institute (ICM) groups have identified \[18F\]-DPA-714 as a promising second-generation TSPO tracer, a macromolecule…NCT06280742·Lyon and 6 others

PreviousPage 102 of 186Next